Skip to main content
Andrew Yee, MD, Pulmonology, Beverly Hills, CA

AndrewYeeMD

Pulmonology • Beverly Hills, CA

Pleural Disease

Physician

Join to view full profile

Are you Dr. Yee?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 50 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    9735 Wilshire Blvd
    Suite 245
    Beverly Hills, CA 90212
    Phone+1 310-276-5298
    Fax+1 310-276-5299

Summary

  • Dr. Andrew Yee, MD is a pulmonologist in Beverly Hills, California. He is currently licensed to practice medicine in California, New Hampshire, and Massachusetts.

Education & Training

  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1980 - 1983
  • Universidad Autonoma de Guadalajara
    Universidad Autonoma de GuadalajaraClass of 1978

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1981 - 2026
  • MA State Medical License
    MA State Medical License 2002 - 2018
  • NH State Medical License
    NH State Medical License 2009 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Study Shows That Immune System Holds Clues to Patients with High-Risk Smoldering Myeloma Likely to Benefit from Treatment
    Study Shows That Immune System Holds Clues to Patients with High-Risk Smoldering Myeloma Likely to Benefit from TreatmentNovember 15th, 2022
  • Karyopharm’s Selinexor Combination for Multiple Myeloma Unlikely to See Second-Line Use Despite Likely FDA Approval
    Karyopharm’s Selinexor Combination for Multiple Myeloma Unlikely to See Second-Line Use Despite Likely FDA ApprovalDecember 18th, 2020
  • Amyloidosis Treatments Miss the Heart of the Problem
    Amyloidosis Treatments Miss the Heart of the ProblemDecember 7th, 2016
  • Join now to see all

Dr. Andrew Yee, Dr. Andrew Yee, MD, Dr. A Yee